📋 Tender Overview
The national diagnostic test continues its production for the priority demand of the Public Health System.The NEOKIT COVID-19 diagnostic tests produced in Argentina which are part of the actions that the Coronavirus Unit of the Ministry of Science Technology and Innovation of the Nation has been carrying out reached one million units in January. supplied to more than twelve provinces which incorporated it into their COVID-19 testing and detection strategy.The rapid sensitive low-cost and simple-to-operate molecular-based test to detect SARS-CoV-2 allowed a significant savings to the provinces compared to imported alternatives and also a significant expansion in the testing capacity due to the simplicity of its execution and the low need for laboratory equipment.The team behind NEOKIT continues to work hard for the supply of the next few months as the vaccination campaign progresses and has a safety stock of 600000 units.NEOKIT COVID-19The rapid diagnostic kit has two qualities it allows to test RNA samples and obtain results in less than two hours with similar sensitivity as current RT-PCR techniques and does not require complete equipment real-time thermal cyclers . The color change from negative violet to positive blue determines a positive test for SARS-CoV-2. This tool streamlines and reinforces the response of healthcare work because in a very short time healthcare teams have the certainty of what decisions to make about the patient with symptoms that is whether to keep him isolated discharge him or carry out some treatment.NEOKIT is a development of the Dr. Cesar Milstein Institute of Science and Technology a double unit CONICET and the Pablo Cassar Foundation. These actors were joined by their marketing efforts by Y-TEC YPFs technology company and CONICET.About the Coronavirus UnitIt is made up of the Ministry of Science Technology and Innovation CONICET and the National Agency for the Promotion of Research Technological Development and Innovation R D i Agency. Its objective is to coordinate the capacities of the scientific and technological system that may be required to carry out diagnostic and research tasks on COVID-19.
